Richard M Jelinek insider trades
Open-market stock purchases and sales by Richard M Jelinek, Director at Evolent Health, Inc, from SEC Form 4 filings since Dec 19, 2017.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -50%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | EVH Evolent Health, Inc | Bought (not open market) | — |